Related Experiment Video
Updated: Mar 8, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Hepatitis E infection among Ghanaians: a systematic review
Richard Ofori-Asenso1, Akosua Adom Agyeman2
1Research Unit, Health Policy Consult, P. O. Box WJ 537, Weija-Accra, Ghana. asensox215@gmail.com.
Hepatitis E virus (HEV) infection is prevalent in Ghana, with serological markers found in 5.8-71.55% of the population. Public health efforts and further research are crucial to manage this significant disease burden.
Area of Science:
- Public Health
- Epidemiology
- Virology
Background:
- Hepatitis E virus (HEV) infection poses a significant public health challenge, particularly in developing nations.
- Understanding the epidemiology of HEV in Ghana is crucial for effective disease control.
Purpose of the Study:
- To summarize existing studies on HEV infection in Ghana.
- To provide a comprehensive overview of HEV epidemiology within the Ghanaian population.
Main Methods:
- A systematic review adhering to PRISMA guidelines was performed.
- Searched multiple databases including PubMed, Web of Science, and Google Scholar for HEV studies in Ghana up to August 2016.
- Included screening of references and relevant government websites for non-indexed studies.
Main Results:
- Ten studies encompassing 2,894 participants across six regions of Ghana were analyzed.
- Serological markers for HEV infection ranged from 5.8% to 71.55%.
- Prevalence of IgM antibodies was 0.7-45.9%, and IgG antibodies was 0-45.3%. A high case fatality rate of 66.7% was noted in pregnant women. Information on HEV genotypes was not available.
Conclusions:
- HEV infection is widespread among Ghanaians, indicating a substantial public health concern.
- Implementing preventive strategies, such as health education and improved sanitation, is essential.
- Further research into HEV genotypes is necessary to fully grasp the disease's impact in Ghana.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

